EcoDrugPlus

Androgen Receptor-Like

Ensembl ID : ENSOMEG00000013757
Gene Symbol: LOC112153467
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSOMEG00000005283
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSOMEG00000019680
Gene Symbol: APH1A
3 Cross references
190 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSOMEG00000018876
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOMEG00000003860
Gene Symbol: ALOX5A
1 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSOMEG00000011641
Gene Symbol: ALOX5AP
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSOMEG00000002961
Gene Symbol: LOC112155872
3 Cross references
200 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSOMEG00000005805
Gene Symbol: LOC112152931
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOMEG00000023294
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOMEG00000000485
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSOMEG00000014043
Gene Symbol: AVPR2
4 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSOMEG00000010567
Gene Symbol: LOC112161048
3 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).